The FDA wants companies that make dermal fillers to treat wrinkles to update their labeling to indicate the risk of injury from unintentional injection into blood vessels.
(Reuters) — The FDA today asked manufacturers of dermal fillers to update their labeling to reflect the possible risk of serious injuries caused by unintentional injection of the fillers into the blood vessels in the face.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1LNiOsa
Cap comentari:
Publica un comentari a l'entrada